Modulation of PPAR-γ by nutraceutics as complementary treatment for obesity-related disorders and inflammatory diseases

PPAR Research

Volumn , Issue , 2012, Pages

  Ortuno Sahagun D ^a   Marquez Aguirre A L ^b   Quintero Fabian S ^a   Lopez Roa R I ^a   Rojas Mayorquin A E ^a,c  

^a UNIVERSITY OF GUADALAJARA   (Mexico)

^b CENTRO DE INVESTIGACIÓN Y ASISTENCIA EN TECNOLOGÍA Y DISEÑO DEL ESTADO DE JALISCO   (Mexico)

^c INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ALLIIN; ALPHA TOCOPHEROL; ALPHA TOCOTRIENOL; BETA CAROTENE; CALCITRIOL; COLECALCIFEROL; CURCUMIN; FLAVONOID; FRUCTOSE OLIGOSACCHARIDE; GAMMA TOCOPHEROL; ICOSAPENTAENOIC ACID; ISOFLAVONE DERIVATIVE; LECTIN; LINOLEIC ACID; NEOLIGNAN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYUNSATURATED FATTY ACID; PROBIOTIC AGENT; QUERCETIN; RESVERATROL; RETINAL; RETINOIC ACID; RETINOL; TRACE ELEMENT; TRITERPENE;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CROHN DISEASE; DIARRHEA; DIET; DIET SUPPLEMENTATION; DIETARY FIBER; ENTERITIS; ENZYME ACTIVATION; ESCHERICHIA COLI; GANODERMA LUCIDUM; GARLIC; HUMAN; INFLAMMATORY DISEASE; LIFESTYLE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRITION; OBESITY; OSTEOPOROSIS; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SACCHAROMYCES CEREVISIAE; ZINGIBERACEAE;

EID: 84871847564     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2012/318613     Document Type: Review

References (208)

1. Tenenbaum A., Fisman E. Z., Motro M., Metabolic syndrome and type 2 diabetes mellitus: focus on peroxisome proliferator activated receptors (PPAR). Cardiovascular Diabetology 2003 2, article 4 2-s2.0-2442671417 10.1186/1475-2840-2-4 (Pubitemid 38751109)
2. Desvergne B., Michalik L., Wahli W., Be fit or be sick: peroxisome proliferator-activated receptors are down the road. Molecular Endocrinology 2004 18 6 1321 1332 2-s2.0-2542454565 10.1210/me.2004-0088 (Pubitemid 38692172)
3. Feige J. N., Gelman L., Michalik L., Desvergne B., Wahli W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions. Progress in Lipid Research 2006 45 2 120 159 2-s2.0-32644460092 10.1016/j.plipres.2005.12.002 (Pubitemid 43248732)
4. Grimaldi P. A., Peroxisome proliferator-activated receptors as sensors of fatty acids and derivatives. Cellular and Molecular Life Sciences 2007 64 19-20 2459 2464 2-s2.0-35648942191 10.1007/s00018-007-7278-5 (Pubitemid 350035619)
5. Tontonoz P., Singer S., Forman B. M., Sarraf P., Fletcher J. A., Fletcher C. D. M., Brun R. P., Mueller E., Altiok S., Oppenheim H., Evans R. M., Spiegelman B. M., Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proceedings of the National Academy of Sciences of the United States of America 1997 94 1 237 241 2-s2.0-12644265334 10.1073/pnas.94.1.237 (Pubitemid 27027193)
6. Yoshizawa K., Cioca D. P., Kawa S., Tanaka E., Kiyosawa K., Peroxisome proliferator-activated receptor γ ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines. Cancer 2002 95 10 2243 2251 2-s2.0-0037110628 10.1002/cncr.10906 (Pubitemid 35253388)
7. Jiang C., Ting A. T., Seed B., PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature 1998 391 6662 82 86 2-s2.0-0031888958 10.1038/34184 (Pubitemid 28079219)
8. Ricote M., Li A. C., Willson T. M., Kelly C. J., Glass C. K., The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 1998 391 6662 79 82 2-s2.0-0031886864 10.1038/34178 (Pubitemid 28079218)
9. Nolan J. J., Ludvik B., Beerdsen P., Joyce M., Olefsky J., Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. The New England Journal of Medicine 1994 331 18 1188 1193 2-s2.0-0027983920 10.1056/NEJM199411033311803 (Pubitemid 24331336)
10. Rizzo G., Disante M., Mencarelli A., Renga B., Gioiello A., Pellicciari R., Fiorucci S., The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo. Molecular Pharmacology 2006 70 4 1164 1173 2-s2.0-33748940093 10.1124/mol.106.023820 (Pubitemid 44435967)
11. Abdelkarim M., Caron S., Duhem C., Prawitt J., Dumont J., Lucas A., Bouchaert E., Briand O., Brozek J., Kuipers F., Fievet C., Cariou B., Staels B., The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-γ and interfering with the Wnt/ β-catenin pathways. The Journal of Biological Chemistry 2010 285 47 36759 36767 2-s2.0-78449258535 10.1074/jbc.M110.166231
12. Brun R. P., Kim J. B., Hu E., Spiegelman B. M., Peroxisome proliferator-activated receptor gamma and the control of adipogenesis. Current Opinion in Lipidology 1997 8 4 212 218 2-s2.0-0030842027 10.1097/00041433- 199708000-00004 (Pubitemid 27354588)
13. Lefterova M. I., Lazar M. A., New developments in adipogenesis. Trends in Endocrinology and Metabolism 2009 20 3 107 114 2-s2.0-62949236601 10.1016/j.tem.2008.11.005
14. Rangwala S. M., Lazar M. A., Transcriptional control of adipogenesis. Annual Review of Nutrition 2000 20 535 559 2-s2.0-0033830783 10.1146/annurev.nutr.20.1.535
15. Rosen E. D., Spiegelman B. M., Molecular regulation of adipogenesis. Annual Review of Cell and Developmental Biology 2000 16 145 171 2-s2.0-0034523640 10.1146/annurev.cellbio.16.1.145 (Pubitemid 32037503)
16. Martin P. G. P., Guillou H., Lasserre F., Déjean S., Lan A., Pascussi J. M., SanCristobal M., Legrand P., Besse P., Pineau T., Novel aspects of PPAR α-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study. Hepatology 2007 45 3 767 777 2-s2.0-33947371320 10.1002/hep.21510 (Pubitemid 46450628)
17. Suh N., Wang Y., Williams C. R., Risingsong R., Gilmer T., Willson T. M., Sporn M. B., A new ligand for the peroxisome proliferator-activated receptor-γ (PPAR-γ), GW7845, inhibits rat mammary carcinogenesis. Cancer Research 1999 59 22 5671 5673 2-s2.0-0033571433
18. Brown P. H., Lippman S. M., Chemoprevention of breast cancer. Breast Cancer Research and Treatment 2000 62 1 1 17 2-s2.0-0033866203 10.1023/A:1006484604454 (Pubitemid 30609560)
19. Anghel S. I., Wahli W., Fat poetry: a kingdom for PPAR γ Cell Research 2007 17 6 486 511 2-s2.0-34250803903 10.1038/cr.2007.48 (Pubitemid 46980946)
20. Gurnell M., 'Striking the right balance' in targeting PPAR γ in the metabolic syndrome: novel insights from human genetic studies. PPAR Research 2007 2-s2.0-42749099527 10.1155/2007/83593 83593 (Pubitemid 46609370)
21. Kershaw E. E., Flier J. S., Adipose tissue as an endocrine organ. Journal of Clinical Endocrinology and Metabolism 2004 89 6 2548 2556 2-s2.0-2942650969 10.1210/jc.2004-0395 (Pubitemid 38766330)
22. Wu G. D., Is there a role for PPAR γ in IBD? Yes, no, maybe. Gastroenterology 2003 124 5 1538 1542 2-s2.0-0037960082 10.1016/S0016-5085(03) 00345-7 (Pubitemid 36531826)
23. Nesto R. W., Bell D., Bonow R. O., Fonseca V., Grundy S. M., Horton E. S., Le Winter M., Porte D., Semenkovich C. F., Smith S., Young L. H., Kahn R., Thiazolidinedione use, fluid retention, and congestive heart failure: a consensus statement from the American Heart Association and American Diabetes Association. Diabetes Care 2004 27 1 256 263 2-s2.0-10744221639 10.2337/diacare.27.1.256 (Pubitemid 38196741)
24. Mencarelli A., Distrutti E., Renga B., D'Amore C., Cipriani S., Palladino G., Donini A., Ricci P., Fiorucci S., Probiotics modulate intestinal expression of nuclear receptor and provide Counter-Regulatory signals to Inflammation-Driven adipose tissue activation. PLoS ONE 2011 6 7, article e22978 2-s2.0-79960963699 10.1371/journal.pone.0022978
25. Cho N., Momose Y., Peroxisome proliferator-activated receptor γ agonists as insulin sensitizers: from the discovery to recent progress. Current Topics in Medicinal Chemistry 2008 8 17 1483 1507 2-s2.0-59149084957 10.2174/156802608786413474
26. Rizos C. V., Elisaf M. S., Mikhailidis D. P., Liberopoulos E. N., How safe is the use of thiazolidinediones in clinical practice? Expert Opinion on Drug Safety 2009 8 1 15 32 2-s2.0-65649099536 10.1517/14740330802597821
27. Newman D. J., Cragg G. M., Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products 2012 75 3 311 335
28. Rau O., Wurglics M., Paulke A., Zitzkowski J., Meindl N., Bock A., Dingermann T., Abdel-Tawab M., Schubert-Zsilavecz M., Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma. Planta Medica 2006 72 10 881 887 2-s2.0-33748588914 10.1055/s-2006-946680 (Pubitemid 44378949)
29. Paliyath G., Bakovic K M., Shetty, Functional Foods, Nutraceuticals, and Degenerative Disease Prevention 2011 1st John Wiley & Sons
30. Haslam D. W., James W. P. T., Obesity. The Lancet 2005 366 9492 1197 1209 2-s2.0-25844457693 10.1016/S0140-6736(05)67483-1 (Pubitemid 41393598)
31. Diplock A. T., Aggett P. J., Ashwell M., Bornet F., Fern E. B., Roberfroid M. B., Scientific concepts of functional foods in Europe: consensus document. British Journal of Nutrition 1999 81 1 I 27 2-s2.0-0033035294
32. Subirade M., Report on Functional Foods 2007 Rome, Italy Food Quality and Standards Service (AGNS) and Food and Agriculture Organization of the United Nations (FAOS)
33. Amiot M. J., Lairon D., Tomás-Barberán F. A., Gil M. I., Fruit and vegetables, cardiovascular disease, diabetes and obesity. Improving the Health-Promoting Properties of Fruit and Vegetable Products 2010 Boca Raton, Fla, USA CRC Press 95 118
34. Von Lintig J., Colors with functions: elucidating the biochemical and molecular basis of carotenoid metabolism. Annual Review of Nutrition 2010 30 35 56 2-s2.0-77955642541 10.1146/annurev-nutr-080508-141027
35. García O. P., Long K. Z., Rosado J. L., Impact of micronutrient deficiencies on obesity. Nutrition Reviews 2009 67 10 559 572 2-s2.0-70350705964 10.1111/j.1753-4887.2009.00228.x
36. Ford E. S., Will J. C., Bowman B. A., Narayan K. M. V., Diabetes mellitus and serum carotenoids: findings from the Third National Health and Nutrition Examination Survey. American Journal of Epidemiology 1999 149 2 168 176 2-s2.0-0033556440 (Pubitemid 29039520)
37. Ylönen K., Alfthan G., Groop L., Saloranta C., Aro A., Virtanen S. M., Dietary intakes and plasma concentrations of carotenoids and tocopherols in relation to glucose metabolism in subjects at high risk of type 2 diabetes: the Botnia Dietary Study. American Journal of Clinical Nutrition 2003 77 6 1434 1441 2-s2.0-0038239388 (Pubitemid 39655276)
38. Coyne T., Ibiebele T. I., Baade P. D., Dobson A., McClintock C., Dunn S., Leonard D., Shaw J., Diabetes mellitus and serum carotenoids: findings of a population-based study in Queensland, Australia. American Journal of Clinical Nutrition 2005 82 3 685 693 2-s2.0-27244451172 (Pubitemid 43759256)
39. Ramakrishna V., Jailkhani R., Oxidative stress in non-insulin-dependent diabetes mellitus (NIDDM) patients. Acta Diabetologica 2008 45 1 41 46 2-s2.0-39049099427 10.1007/s00592-007-0018-3 (Pubitemid 351238275)
40. Burrows T. L., Warren J. M., Colyvas K., Garg M. L., Collins C. E., Validation of overweight children's fruit and vegetable intake using plasma carotenoids. Obesity 2009 17 1 162 168 2-s2.0-57949083153 10.1038/oby.2008.495 (Pubitemid 50324538)
41. Hessel S., Eichinger A., Isken A., Amengual J., Hunzelmann S., Hoeller U., Elste V., Hunziker W., Goralczyk R., Oberhauser V., Von Lintig J., Wyss A., CMO1 deficiency abolishes vitamin a production from β-carotene and alters lipid metabolism in mice. The Journal of Biological Chemistry 2007 282 46 33553 33561 2-s2.0-36349019877 10.1074/jbc.M706763200 (Pubitemid 350159522)
42. Boulanger A., McLemore P., Copeland N. G., Gilbert D. J., Jenkins N. A., Yu S. S., Gentleman S., Redmond T. M., Identification of beta-carotene 15, 159-monooxygenase as a peroxisome proliferator-activated receptor target gene. The FASEB Journal 2003 17 10 1304 1306 2-s2.0-0038265390
43. Gong X., Tsai S. W., Yan B., Rubin L. P., Cooperation between MEF2 and PPAR γ in human intestinal β β-carotene 15, 159-monooxygenase gene expression. BMC Molecular Biology 2006 7, article 7 2-s2.0-33746939839 10.1186/1471-2199-7-7 (Pubitemid 44202696)
44. Lobo G. P., Amengual J., Li H. N. M., Golczak M., Bonet M. L., Palczewski K., Von Lintig J., β β-carotene decreases peroxisome proliferator receptor γ activity and reduces lipid storage capacity of adipocytes in a β β-carotene oxygenase 1-dependent manner. The Journal of Biological Chemistry 2010 285 36 27891 27899 2-s2.0-77956259307 10.1074/jbc.M110.132571
45. Ziouzenkova O., Orasanu G., Sharlach M., Akiyama T. E., Berger J. P., Viereck J., Hamilton J. A., Tang G., Dolnikowski G. G., Vogel S., Duester G., Plutzky J., Retinaldehyde represses adipogenesis and diet-induced obesity. Nature Medicine 2007 13 6 695 702 2-s2.0-34249977327 10.1038/nm1587 (Pubitemid 46889756)
46. Ziouzenkova O., Orasanu G., Sukhova G., Lau E., Berger J. P., Tang G., Krinsky N. I., Dolnikowski G. G., Plutzky J., Asymmetric cleavage of β-carotene yields a transcriptional repressor of retinoid X receptor and peroxisome proliferator-activated receptor responses. Molecular Endocrinology 2007 21 1 77 88 2-s2.0-33845996557 10.1210/me.2006-0225 (Pubitemid 46041692)
47. Stone W. L., Krishnan K., Campbell S. E., Qui M., Whaley S. G., Yang H., Tocopherols and the treatment of colon cancer. Annals of the New York Academy of Sciences 2004 1031 223 233 2-s2.0-14944366499 10.1196/annals.1331.022 (Pubitemid 40361757)
48. Campbell S. E., Stone W. L., Whaley S. G., Qui M., Krishnan K., Gamma (γ) tocopherol upregulates peroxisome proliferator activated receptor (PPAR) gamma (γ) expression in SW 480 human colon cancer cell lines. BMC Cancer 2003 3, article 25 2-s2.0-3042750605 10.1186/1471-2407-3-25 (Pubitemid 38851324)
49. Berry D. C., Noy N., All-trans-retinoic acid represses obesity and insulin resistance by activating both peroxisome proliferation-activated receptor β / δ and retinoic acid receptor. Molecular and Cellular Biology 2009 29 12 3286 3296 2-s2.0-67649211584 10.1128/MCB.01742-08
50. Kris-Etherton P. M., Harris W. S., Appel L. J., Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 2002 106 21 2747 2757 2-s2.0-0037137299 10.1161/01.CIR.0000038493.65177.94 (Pubitemid 35364932)
51. Flachs P., Mohamed-Ali V., Horakova O., Rossmeisl M., Hosseinzadeh-Attar M. J., Hensler M., Ruzickova J., Kopecky J., Polyunsaturated fatty acids of marine origin induce adiponectin in mice fed a high-fat diet. Diabetologia 2006 49 2 394 397 2-s2.0-31844451413 10.1007/s00125-005-0053-y (Pubitemid 43185410)
52. Hwang D., Fatty acids and immune responses-a new perspective in searching for clues to mechanism. Annual Review of Nutrition 2000 20 431 456 2-s2.0-0033835309 10.1146/annurev.nutr.20.1.431
53. Belury M. A., Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annual Review of Nutrition 2002 22 505 531 2-s2.0-0036399826 10.1146/annurev.nutr.22.021302.121842 (Pubitemid 35221471)
54. Mezei O., Banz W. J., Steger R. W., Peluso M. R., Winters T. A., Shay N., Soy isoflavones exert antidiabetic and hypolipidemic effects through the PPAR pathways in obese Zucker rats and murine RAW 264.7 cells. Journal of Nutrition 2003 133 5 1238 1243 2-s2.0-0037657668 (Pubitemid 36548688)
55. Wilkinson A. S., Monteith G. R., Shaw P. N., Lin C. N., Gidley M. J., Roberts-Thomson S. J., Effects of the mango components mangiferin and quercetin and the putative mangiferin metabolite norathyriol on the transactivation of peroxisome proliterator-activated receptor isoforms. Journal of Agricultural and Food Chemistry 2008 56 9 3037 3042 2-s2.0-44349105493 10.1021/jf800046n (Pubitemid 351746026)
56. Sangeetha T., Quine S. D., Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats. Journal of Applied Toxicology 2008 28 5 710 716 2-s2.0-47549101410 10.1002/jat.1330 (Pubitemid 352009763)
57. Kelloff G. J., Boone C. W., Crowell J. A., Steele V. E., Lubet R., Sigman C. C., Chemopreventive drug development: perspectives and progress. Cancer Epidemiology Biomarkers and Prevention 1994 3 1 85 98 2-s2.0-0028232269 (Pubitemid 24172528)
58. Ulrich S., Loitsch S. M., Rau O., Von Knethen A., Brüne B., Schubert-Zsilavecz M., Stein J. M., Peroxisome proliferator-activated receptor γ as a molecular target of resveratrol-induced modulation of polyamine metabolism. Cancer Research 2006 66 14 7348 7354 2-s2.0-33746931148 10.1158/0008-5472.CAN-05-2777 (Pubitemid 44197718)
59. Alberdi G., Rodríguez V. M., Miranda J., MacArulla M. T., Arias N., Andrés-Lacueva C., Portillo M. P., Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutrition and Metabolism 2011 8 1, article 29 2-s2.0-79955721223 10.1186/1743-7075-8-29
60. Lee I., Kim H., Youn U., Kim J., Min B., Jung H., Na M., Hattori M., Bae K., Effect of lanostane triterpenes from the fruiting bodies of Ganoderma lucidum on adipocyte differentiation in 3T3-L1 cells. Planta Medica 2010 76 14 1558 1563 2-s2.0-77957552558 10.1055/s-0030-1249827
61. Delzenne N. M., Williams C. M., Prebiotics and lipid metabolism. Current Opinion in Lipidology 2002 13 1 61 67 2-s2.0-0036176278 10.1097/00041433- 200202000-00009 (Pubitemid 34174630)
62. Czerucka D., Dahan S., Mograbi B., Rossi B., Rampal P., Saccharomyces boulardii preserves the barrier function and modulates the signal transduction pathway induced in enteropathogenic Escherichia coli-infected T84 cells. Infection and Immunity 2000 68 10 5998 6004 2-s2.0-0033806709 10.1128/IAI.68.10.5998-6004.2000
63. Rodrigues A. C. P., Cara D. C., Fretez S. H. G. G., Cunha F. Q., Vieira E. C., Nicoli J. R., Vieira L. Q., Saccharomyces boulardii stimulates sIgA production and the phagocytic system of gnotobiotic mice. Journal of Applied Microbiology 2000 89 3 404 414 2-s2.0-0033833633 10.1046/j.1365-2672.2000.01128. x
64. Eroglu A., Hruszkewycz D. P., Curley R. W., Harrison E. H., The eccentric cleavage product of β-carotene, β-apo-13-carotenone, functions as an antagonist of RXR α Archives of Biochemistry and Biophysics 2010 504 1 11 16 2-s2.0-77957899316 10.1016/j.abb.2010.07.025
65. Amengual J., Gouranton E., van Helden Y. G. J., Hessel S., Ribot J., Kramer E., Kiec-Wilk B., Razny U., Lietz G., Wyss A., Dembinska-Kiec A., Palou A., Keijer J., Landrier J. F., Bonet M. L., von Lintig J., Beta-carotene reduces body adiposity of mice via BCMO1. PLoS ONE 2011 6 6 2-s2.0-79957886723 10.1371/journal.pone.0020644 e20644
66. Wang X., Quinn P. J., Vitamin E and its function in membranes. Progress in Lipid Research 1999 38 4 309 336 2-s2.0-0032859788 10.1016/S0163-7827(99) 00008-9 (Pubitemid 29408248)
67. Constantinou C., Papas A., Constantinou A. I., Vitamin E and cancer: an insight into the anticancer activities of vitamin E isomers and analogs. International Journal of Cancer 2008 123 4 739 752 2-s2.0-47049121032 10.1002/ijc.23689 (Pubitemid 352032398)
68. Traber M. G., Vitamin E regulatory mechanisms. Annual Review of Nutrition 2007 27 347 362 2-s2.0-38449087052 10.1146/annurev.nutr.27.061406.093819 (Pubitemid 351373361)
69. Traber M. G., ShilsME, ShikeM, Ross A. C., Caballero B., Cousins R. J., Vitamin E. Modern Nutrition in Health and Disease 2006 10th Baltimore, Md, USA Lippincott Williams and Wilkins 396 411
70. Fenner M. H., Elstner E., Peroxisome proliferator-activated receptor-γ ligands for the treatment of breast cancer. Expert Opinion on Investigational Drugs 2005 14 6 557 568 2-s2.0-21244432740 10.1517/13543784.14. 6.557 (Pubitemid 40895186)
71. Hong J. L., Ju J., Paul S., So J. Y., DeCastro A., Smolarek A., Lee M. J., Yang C. S., Newmark H. L., Suh N., Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-γ Clinical Cancer Research 2009 15 12 4242 4249 2-s2.0-67449158983 10.1158/1078-0432.CCR- 08-3028
72. Qureshi A. A., Tan X., Reis J. C., Inhibition of nitric oxide in LPS-stimulated macrophages of young and senescent mice by δ-tocotrienol and quercetin. Lipids in Health and Disease 2011 10 239
73. Qureshi A. A., Reis J. C., Qureshi N., Papasian C. J., Morrison D. C., Schaefer D. M., δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens. Lipids in Health and Disease 2011 10, article 39 2-s2.0-79952053160 10.1186/1476-511X-10-39
74. Uto-Kondo H., Ohmori R., Kiyose C., Kishimoto Y., Saito H., Igarashi O., Kondo K., Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadipocytes. Journal of Nutrition 2009 139 1 51 57 2-s2.0-58649087808 10.3945/jn.108.096131
75. Kuri Harcuch W., Differentiation of 3T3-F442A cells into adipocytes is inhibited by retinoic acid. Differentiation 1982 23 2 164 169 2-s2.0-0020467043 (Pubitemid 13144647)
76. Schwarz E. J., Reginato M. J., Shao D., Krakow S. L., Lazar M. A., Retinoic acid blocks adipogenesis by inhibiting C/EBP β-mediated transcription. Molecular and Cellular Biology 1997 17 3 1552 1561 2-s2.0-0031037988 (Pubitemid 27097385)
77. Ribot J., Felipe F., Bonet M. L., Palou A., Changes of adiposity in response to vitamin A status correlate with changes of PPAR γ 2 expression. Obesity Research 2001 9 8 500 509 2-s2.0-0035432378 (Pubitemid 33600294)
78. Hollung K., Rise C. P., Drevon C. A., Reseland J. E., Tissue-specific regulation of leptin expression and secretion by all-trans retinoic acid. Journal of Cellular Biochemistry 2004 92 2 307 315 2-s2.0-16544361808 10.1002/jcb.20047
79. Felipe F., Bonet M. L., Ribot J., Palou A., Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 2004 53 4 882 889 2-s2.0-1842580197 10.2337/diabetes.53.4.882 (Pubitemid 38436599)
80. Felipe F., Mercader J., Ribot J., Palou A., Bonet M. L., Effects of retinoic acid administration and dietary vitamin A supplementation on leptin expression in mice: lack of correlation with changes of adipose tissue mass and food intake. Biochimica et Biophysica Acta 2005 1740 2 258 265 2-s2.0-20444395444 10.1016/j.bbadis.2004.11.014 (Pubitemid 40798236)
81. Mercader J., Granados N., Bonet M. L., Palou A., All-trans retinoic acid decreases murine adipose retinol binding protein 4 production. Cellular Physiology and Biochemistry 2008 22 1-4 363 372 2-s2.0-51149121022 10.1159/000149815
82. Petkovich M., Brand N. J., Krust A., Chambon P., A human retinoic acid receptor which belongs to the family of nuclear receptors. Nature 1987 330 6147 444 450 2-s2.0-0023483399 (Pubitemid 18006425)
83. Aranda A., Pascual A., Nuclear hormone receptors and gene expression. Physiological Reviews 2001 81 3 1269 1304 2-s2.0-0034957480 (Pubitemid 32606670)
84. Shaw N., Elholm M., Noy N., Retinoic acid is a high affinity selective ligand for the peroxisome proliferator-activated receptor β / δ The Journal of Biological Chemistry 2003 278 43 41589 41592 2-s2.0-0142149220 10.1074/jbc.C300368200 (Pubitemid 37310413)
85. Hida Y., Kawada T., Kayahashi S., Ishihara T., Fushiki T., Counteraction of retinoic acid and 1,25-dihydroxyvitamin D3 on up-regulation of adipocyte differentiation with PPAR γ ligand, an antidiabetic thiazolidinedione, in 3T3-L1 cells. Life Sciences 1998 62 14 205 211 2-s2.0-0032570986 (Pubitemid 28153512)
86. Duque G., Macoritto M., Kremer R., 1,25(OH)2D3 inhibits bone marrow adipogenesis in senescence accelerated mice (SAM-P/6) by decreasing the expression of peroxisome proliferator-activated receptor gamma 2 (PPAR γ 2). Experimental Gerontology 2004 39 3 333 338 2-s2.0-1342265406 10.1016/j.exger.2003.11.008 (Pubitemid 38264363)
87. Yaqoob P., Calder P. C., N-3 polyunsaturated fatty acids and inflammation in the arterial wall. European Journal of Medical Research 2003 8 8 337 354 2-s2.0-1542751712
88. Sun D., Krishnan A., Zaman K., Lawrence R., Bhattacharya A., Fernandes G., Dietary n-3 fatty acids decrease osteoclastogenesis and loss of bone mass in ovariectomized Mice. Journal of Bone and Mineral Research 2003 18 7 1206 1216 2-s2.0-0037951860 10.1359/jbmr.2003.18.7.1206 (Pubitemid 37294913)
89. Mori T. A., Bao D. Q., Burke V., Puddey I. B., Beilin L. J., Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans. Hypertension 1999 34 2 253 260 2-s2.0-0032858328 (Pubitemid 29409224)
90. Montori V. M., Farmer A., Wollan P. C., Dinneen S. F., Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 2000 23 9 1407 1415 2-s2.0-0033851158
91. Storlien L. H., Kraegen E. W., Chisholm D. J., Fish oil prevents insulin resistance induced by high-fat feeding in rats. Science 1987 237 4817 885 888 2-s2.0-0023240831 (Pubitemid 17128276)
92. Neschen S., Morino K., Dong J., Wang-Fischer Y., Cline G. W., Romanelli A. J., Rossbacher J. C., Moore I. K., Regittnig W., Munoz D. S., Kim J. H., Shulman G. I., n-3 fatty acids preserve insulin sensitivity in vivo in a peroxisome proliferator-activated receptor-α-dependent manner. Diabetes 2007 56 4 1034 1041 2-s2.0-34047166373 10.2337/db06-1206 (Pubitemid 46525082)
93. Calder P. C., n-3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases. American Journal of Clinical Nutrition 2006 83 6 1505S 1519S 2-s2.0-33746830525 (Pubitemid 44713092)
94. Connor W. E., Importance of n-3 fatty acids in health and disease. American Journal of Clinical Nutrition 2000 71 1 171S 175S 2-s2.0-0033972318 (Pubitemid 30046112)
95. Duda M. K., O'Shea K. M., Lei B., Barrows B. R., Azimzadeh A. M., McElfresh T. E., Hoit B. D., Kop W. J., Stanley W. C., Dietary supplementation with ω-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload. Cardiovascular Research 2007 76 2 303 310 2-s2.0-36649034268 10.1016/j.cardiores.2007.07.002 (Pubitemid 350198598)
96. Puglisi M. J., Hasty A. H., Saraswathi V., The role of adipose tissue in mediating the beneficial effects of dietary fish oil. Journal of Nutritional Biochemistry 2011 22 2 101 108 2-s2.0-78651249542 10.1016/j.jnutbio.2010.07.003
97. Yamamoto K., Itoh T., Abe D., Shimizu M., Kanda T., Koyama T., Nishikawa M., Tamai T., Ooizumi H., Yamada S., Identification of putative metabolites of docosahexaenoic acid as potent PPAR γ agonists and antidiabetic agents. Bioorganic and Medicinal Chemistry Letters 2005 15 3 517 522 2-s2.0-19944431858 10.1016/j.bmcl.2004.11.053
98. Jump D. B., N-3 polyunsaturated fatty acid regulation of hepatic gene transcription. Current Opinion in Lipidology 2008 19 3 242 247 2-s2.0-43249114663 10.1097/MOL.0b013e3282ffaf6a (Pubitemid 351653561)
99. González-Périz A., Horrillo R., Ferré N., Gronert K., Dong B., Morán-Salvador E., Titos E., Martínez-Clemente M., López-Parra M., Arroyo V., Clària J., Obesity-induced insulin resistance and hepatic steatosis are alleviated by ω-3 fatty acids: a role for resolvins and protectins. FASEB Journal 2009 23 6 1946 1957 2-s2.0-67649363782 10.1096/fj.08-125674
100. Gani O. A. B. S. M., Are fish oil omega-3 long-chain fatty acids and their derivatives peroxisome proliferator-activated receptor agonists? Cardiovascular Diabetology 2008 7, article 6 2-s2.0-42449125303 10.1186/1475-2840-7-6 (Pubitemid 351566901)
101. Turpeinen A. M., Mutanen M., Aro A., Salminen I., Basu S., Palmquist D. L., Griinari J. M., Bioconversion of vaccenic acid to conjugated linoleic acid in humans. American Journal of Clinical Nutrition 2002 76 3 504 510 2-s2.0-0036720997 (Pubitemid 34920825)
102. Bassaganya-Riera J., Hontecillas R., Beitz D. C., Colonic anti-inflammatory mechanisms of conjugated linoleic acid. Clinical Nutrition 2002 21 6 451 459 2-s2.0-0036905233 10.1054/clnu.2002.0594 (Pubitemid 35452508)
103. Moya-Camarena S. Y., Vanden Heuvel J. P., Blanchard S. G., Leesnitzer L. A., Belury M. A., Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPAR α Journal of Lipid Research 1999 40 8 1426 1433 2-s2.0-0032796505 (Pubitemid 29379982)
104. Kelley D. S., Taylor P. C., Nelson G. J., Schmidt P. C., Ferretti A., Erickson K. L., Ranjit K., Mackey B. E., Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999 34 4 317 324 2-s2.0-0032895369 10.1007/s11745-999-0369- 5 (Pubitemid 29230271)
105. Kew S., Gibbons E. S., Thies F., McNeill G. P., Quinlan P. T., Calder P. C., The effect of feeding structured triacylglycerols enriched in eicosapentaenoic or docosahexaenoic acids on murine splenocyte fatty acids composition and leucocyte phagocytosis. British Journal of Nutrition 2003 90 6 1071 1080 2-s2.0-0346749819 10.1079/BJN2003996 (Pubitemid 37548039)
106. Serhan C. N., Clish C. B., Brannon J., Colgan S. P., Chiang N., Gronert K., Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. Journal of Experimental Medicine 2000 192 8 1197 1204 2-s2.0-0034675852 10.1084/jem.192.8.1197
107. Bhattacharya A., Banu J., Rahman M., Causey J., Fernandes G., Biological effects of conjugated linoleic acids in health and disease. Journal of Nutritional Biochemistry 2006 17 12 789 810 2-s2.0-33750935990 10.1016/j.jnutbio.2006.02.009 (Pubitemid 44738517)
108. Alibin C. P., Kopilas M. A., Anderson H. D. I., Suppression of cardiac myocyte hypertrophy by conjugated linoleic acid: role of peroxisome proliferator-activated receptors α and γ The Journal of Biological Chemistry 2008 283 16 10707 10715 2-s2.0-44849113266 10.1074/jbc.M800035200
109. Wang Y. W., Jones P. J. H., Conjugated linoleic acid and obesity control: efficacy and mechanisms. International Journal of Obesity 2004 28 8 941 955 2-s2.0-3242884783 10.1038/sj.ijo.0802641 (Pubitemid 38998698)
110. Whigham L. D., Watras A. C., Schoeller D. A., Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans. American Journal of Clinical Nutrition 2007 85 5 1203 1211 2-s2.0-34248370966 (Pubitemid 46740460)
111. Wahle K. W. J., Heys S. D., Rotondo D., Conjugated linoleic acids: are they beneficial or detrimental to health? Progress in Lipid Research 2004 43 6 553 587 2-s2.0-7444271915 10.1016/j.plipres.2004.08.002 (Pubitemid 39441346)
112. Tsuboyama-Kasaoka N., Takahashi M., Tanemura K., Kim H. J., Tange T., Okuyama H., Kasai M., Ikemoto S., Ezaki O., Conjugated linoleic acid supplementation reduces adipose tissue by apoptosis and develops lipodystrophy in mice. Diabetes 2000 49 9 1534 1542 2-s2.0-0033861304
113. Moloney F., Yeow T. P., Mullen A., Nolan J. J., Roche H. M., Conjugated linoleic acid supplementation, insulin sensitivity, and lipoprotein metabolism in patients with type 2 diabetes mellitus. American Journal of Clinical Nutrition 2004 80 4 887 895 2-s2.0-5144228885 (Pubitemid 41202087)
114. Risérus U., Arner P., Brismar K., Vessby B., Treatment with dietary trans10cis12 conjugated linoleic acid causes isomer-specific insulin resistance in obese men with the metabolic syndrome. Diabetes Care 2002 25 9 1516 1521 2-s2.0-0036730666 10.2337/diacare.25.9.1516 (Pubitemid 41071104)
115. Risérus U., Vessby B., Arner P., Zethelius B., Supplementation with trans10cis12-conjugated linoleic acid induces hyperproinsulinaemia in obese men: close association with impaired insulin sensitivity. Diabetologia 2004 47 6 1016 1019 2-s2.0-17144434666 (Pubitemid 38918160)
116. DeLany J. P., Blohm F., Truett A. A., Scimeca J. A., West D. B., Conjugated linoleic acid rapidly reduces body fat content in mice without affecting energy intake. American Journal of Physiology 1999 276 4 R1172 R1179 2-s2.0-0032938104 (Pubitemid 29214192)
117. Poirier H., Niot I., Clément L., Guerre-Millo M., Besnard P., Development of conjugated linoleic acid (CLA)-mediated lipoatrophic syndrome in the mouse. Biochimie 2005 87 1 73 79 2-s2.0-14544287769 10.1016/j.biochi.2004. 11.006 (Pubitemid 40298768)
118. Halade G. V., Rahman M. M., Williams P. J., Fernandes G., Combination of conjugated linoleic acid with fish oil prevents age-associated bone marrow adiposity in C57Bl/6J mice. Journal of Nutritional Biochemistry 2011 22 5 459 469 2-s2.0-79954571944 10.1016/j.jnutbio.2010.03.015
119. Pérez-Cano F. J., Ramírez-Santana C., Molero-Luís M., Castell M., Rivero M., Castellote C., Franch À.., Mucosal IgA increase in rats by continuous CLA feeding during suckling and early infancy. Journal of Lipid Research 2009 50 3 467 476 2-s2.0-64349088288 10.1194/jlr.M800356-JLR200
120. Hensler M., Bardova K., Jilkova Z. M., Wahli W., Meztger D., Chambon P., Kopecky J., Flachs P., The inhibition of fat cell proliferation by n-3 fatty acids in dietary obese mice. Lipids in Health and Disease 2011 10 128 2-s2.0-79960892660 10.1186/1476-511X-10-128
121. Dang Z. C., Audinot V., Papapoulos S. E., Boutin J. A., Löwik C. W. G. M., PPAR γ as a molecular target for the soy phytoestrogen genistein. The Journal of Biological Chemistry 2003 278 2 962 967 2-s2.0-0037428403 10.1074/jbc.M209483200 (Pubitemid 36790772)
122. Kim S., Shin H. J., Kim S. Y., Kim J. H., Lee Y. S., Kim D. H., Lee M. O., Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPAR α Molecular and Cellular Endocrinology 2004 220 1-2 51 58 2-s2.0-2942529395 10.1016/j.mce.2004.03.011 (Pubitemid 38757880)
123. Ricketts M. L., Moore D. D., Banz W. J., Mezei O., Shay N. F., Molecular mechanisms of action of the soy isoflavones includes activation of promiscuous nuclear receptors. A review. Journal of Nutritional Biochemistry 2005 16 6 321 330 2-s2.0-20144375350 10.1016/j.jnutbio.2004.11.008 (Pubitemid 40776040)
124. Mezei O., Li Y., Mullen E., Ross-Viola J. S., Shay N. F., Dietary isoflavone supplementation modulates lipid metabolism via PPAR α-dependent
125. Yeh S. L., Yeh C. L., Chan S. T., Chuang C. H., Plasma rich in quercetin metabolites induces G2/M arrest by upregulating PPAR-expression in human A549 lung cancer cells. Planta Medica 2011 77 10 992 998 2-s2.0-79959938448 10.1055/s-0030-1250735
126. Kobori M., Masumoto S., Akimoto Y., Oike H., Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Molecular Nutrition and Food Research 2011 55 4 530 540 2-s2.0-79953317030 10.1002/mnfr.201000392
127. McMichael-Phillips D. F., Harding C., Morton M., Roberts S. A., Howell A., Potten C. S., Bundred N. J., Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast. American Journal of Clinical Nutrition 1998 68 6 1431S 1435S 2-s2.0-0031740854
128. Sirtori C. R., Arnoldi A., Johnson S. K., Phytoestrogens: end of a tale? Annals of Medicine 2005 37 6 423 438 2-s2.0-26944477010 10.1080/ 07853890510044586 (Pubitemid 41476128)
129. Bajaj M., Hinge A., Limaye L. S., Gupta R. K., Surolia A., Kale V. P., Mannose-binding dietary lectins induce adipogenic differentiation of the marrow-derived mesenchymal cells via an active insulin-like signaling mechanism. Glycobiology 2011 21 4 521 529 2-s2.0-79952540480 10.1093/glycob/cwq194
130. Hinge A., Bajaj M., Limaye L., Surolia A., Kale V., Oral administration of insulin receptor-interacting lectins leads to an enhancement in the hematopoietic stem and progenitor cell pool of mice. Stem Cells and Development 2010 19 2 163 173 2-s2.0-77649115473 10.1089/scd.2009.0128
131. Hodge G., Hodge S., Han P., Allium sativum (garlic) suppresses leukocyte inflammatory cytokine production in vitro: potential therapeutic use in the treatment of inflammatory bowel disease. Cytometry 2002 48 4 209 215 2-s2.0-0036702712 10.1002/cyto.10133 (Pubitemid 35333951)
132. Iciek M., Kwiecieri I., Włodek L., Biological properties of garlic and garlic-derived organosulfur compounds. Environmental and Molecular Mutagenesis 2009 50 3 247 265 2-s2.0-63049130448 10.1002/em.20474
133. Chai H., Wo L., Fu Y., Xie T., Wang Q., Huang L., S-allyl-L-cysteine sulfoxide inhibits tumor necrosis factor-alpha induced monocyte adhesion and intercellular cell adhesion molecule-1 expression in human umbilical vein endothelial cells. Anatomical Record 2010 293 3 421 430 2-s2.0-77149123340 10.1002/ar.21070
134. Nasim S. A., Dhir B., Kapoor R., Alliin obtained from leaf extract of garlic grown under in situ conditions possess higher therapeutic potency as analyzed in alloxan-induced diabetic rats. Pharmaceutical Biology 2011 49 4 416 421 2-s2.0-79953086060 10.3109/13880209.2010.521163
135. Apitz-Castro R., Badimon J. J., Badimon L., Effect of ajoene, the major antiplatelet compound from garlic, on platelet thrombus formation. Thrombosis Research 1992 68 2 145 155 2-s2.0-0026494991 10.1016/0049-3848(92)90030-E
136. Egen-Schwind C., Eckard R., Jekat F. W., Winterhoff H., Pharmacokinetics of vinyldithiins, transformation products of allicin. Planta Medica 1992 58 1 8 13 2-s2.0-0026547037
137. Keophiphath M., Priem F., Jacquemond-Collet I., Clément K., Lacasa D., 1,2-Vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. Journal of Nutrition 2009 139 11 2055 2060 2-s2.0-70350313238 10.3945/jn.109.105452
138. Lee J. H., Kim K. A., Kwon K. B., Kim E. K., Lee Y. R., Song M. Y., Koo J. H., Ka S. O., Park J. W., Park B. H., Diallyl disulfide accelerates adipogenesis in 3T3-L1 cells. International Journal of Molecular Medicine 2007 20 1 59 64 2-s2.0-34548088205
139. Quintero-Fabián M. S., Ortuño-Sahagún D., Vázquez-Carrera M., López-Roa R. I., Effect of alliin on the adipokines gene expression in an inflammatory in vitro model of 3T3-L1 adipocytes. Proceedings of the 1st FALAN Meeting 2012
140. Chen A. L., Hsu C. H., Lin J. K., Hsu M. M., Ho Y. F., She T. S., Ko J. Y., Lin J. T., Lin B. R., Wu M. S., Yu H. S., Jee S. H., Chen G. S., Chen T. M., Chen C. A., Lai M. K., Pu Y. S., Pan M. H., Wang Y. J., Tsai C. C., Hsieh C. Y., Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Research 2001 21 4 2895 2900 2-s2.0-0035174504
141. Chan M. M. Y., Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochemical Pharmacology 1995 49 11 1551 1556 2-s2.0-0029047933 10.1016/0006-2952(95)00171-U
142. Brouet I., Ohshima H., Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochemical and Biophysical Research Communications 1995 206 2 533 540 2-s2.0-0028928877 10.1006/bbrc.1995.1076
143. Chan M. M. Y., Huang H. I., Fenton M. R., Fong D., In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochemical Pharmacology 1998 55 12 1955 1962 2-s2.0-0032525741 10.1016/S0006-2952(98)00114-2 (Pubitemid 28477465)
144. Welch J. S., Ricote M., Akiyama T. E., Gonzalez F. J., Glass C. K., PPAR γ and PPAR δ negatively regulate specific subsets of lipopolysaccharide and IFN-γ target genes in macrophages. Proceedings of the National Academy of Sciences of the United States of America 2003 100 11 6712 6717 2-s2.0-0038460253 10.1073/pnas.1031789100 (Pubitemid 36666645)
145. Chen A., Xu J., Activation of PPAR γ by curcumin inhibits Moser cell growth and mediates suppression of gene expression of cyclin D1 and EGFR. American Journal of Physiology 2005 288 3 G447 G456 2-s2.0-13844306722 10.1152/ajpgi.00209.2004 (Pubitemid 40261742)
146. Siddiqui A. M., Cui X., Wu R., Dong W., Zhou M., Hu M., Simms H. H., Wang P., The anti-inflammatory effect of curcumin in an experimental model of sepsis is mediated by up-regulation of peroxisome proliferator-activated receptor-γ Critical Care Medicine 2006 34 7 1874 1882 2-s2.0-33745632762 10.1097/01.CCM.0000221921.71300.BF (Pubitemid 43982462)
147. Adapala N., Chan M. M., Long-term use of an antiinflammatory, curcumin, suppressed type 1 immunity and exacerbated visceral leishmaniasis in a chronic experimental model. Laboratory Investigation 2008 88 12 1329 1339 2-s2.0-56649094498 10.1038/labinvest.2008.90
148. Zheng S., Chen A., Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator- activated receptor-γ in rat hepatic stellate cells. American Journal of Physiology 2007 292 1 G113 G123 2-s2.0-33846146367 10.1152/ajpgi.00200.2006 (Pubitemid 46090257)
149. Camins A., Junyent F., Verdaguer E., Resveratrol: an antiaging drug with potential therapeutic applications in treating diseases. Pharmaceuticals 2009 2 3 194 205
150. Rayalam S., Della-Fera M. A., Yang J. Y., Hea J. P., Ambati S., Baile C. A., Resveratrol potentiates genistein's antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. Journal of Nutrition 2007 137 12 2668 2673 2-s2.0-37149009308 (Pubitemid 350255295)
151. Floyd Z. E., Wang Z. Q., Kilroy G., Cefalu W. T., Modulation of peroxisome proliferator-activated receptor γ stability and transcriptional activity in adipocytes by resveratrol. Metabolism 2008 57 1 S32 S38 2-s2.0-44949129961 10.1016/j.metabol.2008.04.006 (Pubitemid 351814704)
152. Zhang H. Y., Du Z. X., Meng X., Resveratrol prevents TNF α-induced suppression of adiponectin expression via PPAR γ activation in 3T3-L1 adipocytes. Clinical and Experimental Medicine. In press 10.1007/s10238-012- 0189-2
153. Costa C. D. S., Rohden F., Hammes T. O., Margis R., Bortolotto J. W., Padoin A. V., Mottin C. C., Guaragna R. M., Resveratrol upregulated SIRT1, FOXO1, and adiponectin and downregulated PPAR γ 1-3 mRNA expression in human visceral adipocytes. Obesity Surgery 2011 21 3 356 361 2-s2.0-79955781048 10.1007/s11695-010-0251-7
154. Zhang Y., Luo Z., Ma L., Xu Q., Yang Q., Si L., Resveratrol prevents the impairment of advanced glycosylation end products (AGE) on macrophage lipid homeostasis by suppressing the receptor for AGE via peroxisome proliferator-activated receptor γ activation. International Journal of Molecular Medicine 2010 25 5 729 734 2-s2.0-77951737083 10.3892/ijmm-00000398
155. Xu Z., Chen X., Zhong Z., Chen L., Wang Y., Ganoderma lucidum polysaccharides: immunomodulation and potential anti-tumor activities. American Journal of Chinese Medicine 2011 39 1 15 27 2-s2.0-78751493724 10.1142/S0192415X11008610
156. Shimojo Y., Kosaka K., Shirasawa T., Effect of Ganoderma lucidum extract on adipocyte differentiation and adiponectin gene expression in the murine pre-adipocyte cell line, 3T3-L1. Phytotherapy Research 2011 25 2 202 207 2-s2.0-79551664967 10.1002/ptr.3242
157. Thyagarajan-Sahu A., Lane B., Sliva D., ReishiMax, mushroom based dietary supplement, inhibits adipocyte differentiation, stimulates glucose uptake and activates AMPK. BMC Complementary and Alternative Medicine 2011 11 74
158. Roberfroid M. H., Inuline-Type Fructans Functional Foods Ingredients 2005 CRC Series in Modern Nutrition
159. Cani P. D., Delzenne N. M., Interplay between obesity and associated metabolic disorders: new insights into the gut microbiota. Current Opinion in Pharmacology 2009 9 6 737 743 2-s2.0-70449574399 10.1016/j.coph.2009.06.016
160. Zenhom M., Hyder A., de Vrese M., Heller K. J., Roeder T., Schrezenmeir J., Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal Caco-2 cells via activation of PPAR γ and peptidoglycan recognition protein 3. Journal of Nutrition 2011 141 5 971 977 2-s2.0-79955497844 10.3945/jn.110.136176
161. Pattenden G., Natural 4-ylidenebutenolides and 4-ylidenetetronic acids. Fortschritte der Chemie Organischer Naturstoffe 1978 35 133 198 2-s2.0-0018174289 (Pubitemid 8406537)
162. Haworth R. D., Natural resins. Annual Report on the Progress of Chemistry 1936 33 266
163. Fakhrudin N., Ladurner A., Atanasov A. G., Heiss E. H., Baumgartner L., Markt P., Schuster D., Ellmerer E. P., Wolber G., Rollinger J. M., Stuppner H., Dirsch V. M., Computer-aided discovery, validation, and mechanistic characterization of novel neolignan activators of peroxisome proliferator-activated receptor γ Molecular Pharmacology 2010 77 4 559 566 2-s2.0-77950253421 10.1124/mol.109.062141
164. Schrezenmeir J., De Vrese M., Probiotics, prebiotics, and synbiotics-approaching a definition. American Journal of Clinical Nutrition 2001 73 2 361 364 2-s2.0-0035150737
165. Lam B., Younossi Z. M., Review: treatment options for nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology 2010 3 2 121 137 2-s2.0-77953444310 10.1177/1756283X09359964
166. Zanello G., Meurens F., Berri M., Salmon H., Saccharomyces boulardii effects on gastrointestinal diseases. Current Issues in Molecular Biology 2009 11 47 58 2-s2.0-54849423926
167. Wu X., Vallance B. A., Boyer L., Bergstrom K. S. B., Walker J., Madsen K., O'Kusky J. R., Buchan A. M., Jacobson K., Saccharomyces boulardii ameliorates Citrobacter rodentium-induced colitis through actions on bacterial virulence factors. American Journal of Physiology 2007 294 1 G295 G306 2-s2.0-38349092363 10.1152/ajpgi.00173.2007
168. Castagliuolo I., Riegler M. F., Valenick L., LaMont J. T., Pothoulakis C., Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa. Infection and Immunity 1999 67 1 302 307 2-s2.0-0032919855 (Pubitemid 29021663)
169. Mumy K. L., Chen X., Kelly C. P., McCormick B. A., Saccharomyces boulardii interferes with Shigella pathogenesis by postinvasion signaling events. American Journal of Physiology 2008 294 3 G599 G609 2-s2.0-41549123221 10.1152/ajpgi.00391.2007 (Pubitemid 351468759)
170. Martins F. S., Dalmasso G., Arantes R. M. E., Doye A., Lemichez E., Lagadec P., Imbert V., Peyron J. F., Rampal P., Nicoli J. R., Czerucka D., Interaction of Saccharomyces boulardii with Salmonella enterica serovar typhimurium protects mice and modifies T84 cell response to the infection. PLoS ONE 2010 5 1, article e8925 2-s2.0-77952522194 10.1371/journal.pone.0008925
171. Zanello G., Berri M., Dupont J., Sizaret P. Y., D'Inca R., Salmon H., Meurens F., Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells. PLoS ONE 2011 6 4, article e18573 2-s2.0-79953680466 10.1371/journal.pone.0018573
172. Lee S. K., Kim H. J., Chi S. G., Jang J. Y., Nam K. D., Kim N. H., Joo K. R., Dong S. H., Kim B. H., Chang Y. W., Lee J. I., Chang R., Saccharomyces boulardii activates expression of peroxisome proliferator-activated receptor-gamma in HT-29 cells. The Korean Journal of Gastroenterology 2005 45 5 328 334 2-s2.0-33747738231
173. Pothoulakis C., Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Alimentary Pharmacology and Therapeutics 2009 30 8 826 833 2-s2.0-70349213718 10.1111/j.1365-2036.2009.04102.x
174. Lee S. K., Kim Y. W., Chi S. G., Joo Y. S., Kim H. J., The effect of saccharomyces boulardii on human colon cells and inflammation in rats with trinitrobenzene sulfonic acid-induced colitis. Digestive Diseases and Sciences 2009 54 2 255 263 2-s2.0-59449084229 10.1007/s10620-008-0357-0
175. Nissle A., Die antagonistische behandlung chronischer darmstorungen mit colibakterien. Medizinische Klinik 1918 2 29 33
176. Jacobi C. A., Malfertheiner P., Escherichia coli Nissle 1917 (Mutaflor): new insights into an old probiotic bacterium. Digestive Diseases 2011 29 6 600 607
177. Schulze J., Sonnenborn U., 120 Jahre E. coli: bedeutung in forschung und medizin. Hagen: Alfred-Nissle-Gesellschafte. V. 2006
178. Konturek P. C., Sliwowski Z., Koziel J., Ptak-Belowska A., Burnat G., Brzozowski T., Konturek S. J., Probiotic bacteria Escherichia coli strain Nissle 1917 attenuates acute gastric lesions induced by stress. Journal of Physiology and Pharmacology 2009 60 41 48 2-s2.0-77954513742
179. Reiff C., Delday M., Rucklidge G., Reid M., Duncan G., Wohlgemuth S., Hörmannsperger G., Loh G., Blaut M., Collie-Duguid E., Haller D., Kelly D., Balancing inflammatory, lipid, and xenobiotic signaling pathways by VSL#3, a biotherapeutic agent, in the treatment of inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 11 1721 1736 2-s2.0-71949095393 10.1002/ibd.20999
180. Ewaschuk J. B., Walker J. W., Diaz H., Madsen K. L., Bioproduction of conjugated linoleic acid by probiotic bacteria occurs in vitro and in vivo in mice. Journal of Nutrition 2006 136 6 1483 1487 2-s2.0-33646792251 (Pubitemid 43765349)
181. Boss O., Bergenhem N., Adipose targets for obesity drug development. Expert Opinion on Therapeutic Targets 2006 10 1 119 134 2-s2.0-33144469701 10.1517/14728222.10.1.119 (Pubitemid 43263270)
182. Bäckhed F., Ding H., Wang T., Hooper L. V., Gou Y. K., Nagy A., Semenkovich C. F., Gordon J. I., The gut microbiota as an environmental factor that regulates fat storage. Proceedings of the National Academy of Sciences of the United States of America 2004 101 44 15718 15723 2-s2.0-8144226856 10.1073/pnas.0407076101 (Pubitemid 39473554)
183. Bäckhed F., Manchester J. K., Semenkovich C. F., Gordon J. I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proceedings of the National Academy of Sciences of the United States of America 2007 104 3 979 984 2-s2.0-33846542071 10.1073/pnas.0605374104 (Pubitemid 46154722)
184. Wen L., Ley R. E., Volchkov P. Y., Stranges P. B., Avanesyan L., Stonebraker A. C., Hu C., Wong F. S., Szot G. L., Bluestone J. A., Gordon J. I., Chervonsky A. V., Innate immunity and intestinal microbiota in the development of Type 1 diabetes. Nature 2008 455 7216 1109 1113 2-s2.0-54549122338 10.1038/nature07336
185. Einarsson K., Gustafsson J. A., Gustafsson B. E., Differences between germ free and conventional rats in liver microsomal metabolism of steroids. The Journal of Biological Chemistry 1973 248 10 3623 3630 2-s2.0-0015876420
186. Einarsson K., Gustafsson J. A., Gustafsson B. E., Hepatic 3 hydroxy 3 methylglutaryl CoA reductase activity in germfree rats. Proceedings of the Society for Experimental Biology and Medicine 1977 154 3 319 321 2-s2.0-0017376563 (Pubitemid 8092434)
187. Gustafsson B. E., Angelin B., Einarsson K., Gustafsson J. A., Effects of cholesterol feeding on synthesis and metabolism of cholesterol and bile acids in germfree rats. Journal of Lipid Research 1977 18 6 717 721 2-s2.0-0017665396 (Pubitemid 8238667)
188. Desreumaux P., Dubuquoy L., Nutten S., Peuchmaur M., Englaro W., Schoonjans K., Derijard B., Desvergne B., Wahli W., Chambon P., Leibowitz M. D., Colombel J. F., Auwerx J., Attenuation of colon inflammation through activators of the retinoid X receptor (RXR)/peroxisome proliferator-activated receptor γ (PPAR γ) heterodimer: a basis for new therapeutic strategies. Journal of Experimental Medicine 2001 193 7 827 838 2-s2.0-0035794293 10.1084/jem.193.7.827 (Pubitemid 32524532)
189. Chawla A., Barak Y., Nagy L., Liao D., Tontonoz P., Evans R. M., PPAR-γ dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation. Nature Medicine 2001 7 1 48 52 2-s2.0-0035132330 10.1038/83336 (Pubitemid 32095641)
190. Vavassori P., Mencarelli A., Renga B., Distrutti E., Fiorucci S., The bile acid receptor FXR is a modulator of intestinal innate immunity. Journal of Immunology 2009 183 10 6251 6261 2-s2.0-77149159568 10.4049/jimmunol.0803978
191. Rumi G., Tsubouchi R., Okayama M., Kato S., Mózsik G., Takeuchi K., Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats. Digestive Diseases and Sciences 2004 49 9 1466 1472 2-s2.0-4644338124 10.1023/B:DDAS.0000042248.48819.ad (Pubitemid 39273624)
192. Lara-Villoslada F., Debras E., Nieto A., Concha A., Gálvez J., López-Huertas E., Boza J., Obled C., Xaus J., Oligosaccharides isolated from goat milk reduce intestinal inflammation in a rat model of dextran sodium sulfate-induced colitis. Clinical Nutrition 2006 25 3 477 488 2-s2.0-33744944291 10.1016/j.clnu.2005.11.004 (Pubitemid 43843021)
193. Lindsay J. O., Whelan K., Stagg A. J., Gobin P., Al-Hassi H. O., Rayment N., Kamm M. A., Knight S. C., Forbes A., Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn's disease. Gut 2006 55 3 348 355 2-s2.0-33144470875 10.1136/gut.2005.074971
194. Winkler J., Butler R., Symonds E., Fructo-oligosaccharide reduces inflammation in a dextran sodium sulphate mouse model of colitis. Digestive Diseases and Sciences 2007 52 1 52 58 2-s2.0-33846286520 10.1007/s10620-006- 9224-z (Pubitemid 46122047)
195. Lakatos P. L., Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World Journal of Gastroenterology 2006 12 38 6102 6108 2-s2.0-33750609696 (Pubitemid 44688157)
196. Joseph S. B., Castrillo A., Laffitte B. A., Mangelsdorf D. J., Tontonoz P., Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nature Medicine 2003 9 2 213 219 2-s2.0-0037324340 10.1038/nm820 (Pubitemid 36227724)
197. Fiorucci S., Cipriani S., Mencarelli A., Renga B., Distrutti E., Baldelli F., Counter-regulatory role of bile acid activated receptors in immunity and inflammation. Current Molecular Medicine 2010 10 6 579 595 2-s2.0-77958004743
198. Mach T., Clinical usefulness of probiotics in inflammatory bowel diseases. Journal of Physiology and Pharmacology 2006 57 9 23 33 2-s2.0-34147095993
199. Dubuquoy L., Rousseaux C., Thuru X., Peyrin-Biroulet L., Romano O., Chavatte P., Chamaillard M., Desreumaux P., PPAR γ as a new therapeutic target in inflammatory bowel diseases. Gut 2006 55 9 1341 1349 2-s2.0-33747777758 10.1136/gut.2006.093484 (Pubitemid 44277368)
200. Bassaganya-Riera J., Hontecillas R., Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in inflammatory bowel disease. Current Opinion in Clinical Nutrition and Metabolic Care 2010 13 5 569 573 2-s2.0-77955920757 10.1097/MCO.0b013e32833b648e
201. Nieto N., Torres M. I., Ŕ os A., Gil A., Dietary polyunsaturated fatty acids improve histological and biochemical alterations in rats with experimental ulcerative colitis. Journal of Nutrition 2002 132 1 11 19 2-s2.0-0036138758 (Pubitemid 34042448)
202. Shih D. Q., Targan S. R., Immunopathogenesis of inflammatory bowel disease. World Journal of Gastroenterology 2008 14 3 390 400 2-s2.0-40049108461 10.3748/wjg.14.390 (Pubitemid 351320847)
203. Desreumaux P., Ernst O., Geboes K., Gambiez L., Berrebi D., Muller-Alouf H., Hafraoui S., Emilie D., Ectors N., Peuchmaur M., Cortot A., Capeon M., Auwerx J., Colombel J. F., Inflammatory alterations in mesenteric adipose tissue in Crohn's disease. Gastroenterology 1999 117 1 73 81 2-s2.0-0033040282 10.1016/S0016-5085(99)70552-4 (Pubitemid 29297622)
204. Schäffler A., Schölmerich J., Büchler C., Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in nonalcoholic fatty liver disease. Nature Clinical Practice Gastroenterology and Hepatology 2005 2 6 273 280 2-s2.0-21244450310 10.1038/ncpgasthep0186 (Pubitemid 40895403)
205. Karagiannides I., Kokkotou E., Tansky M., Tchkonia T., Giorgadza N., O'Brien M., Leeman S. E., Kirkland J. L., Pothoulakis C., Induction of colitis causes inflammatory responses in fat depots: evidence for substance P pathways in human mesenteric preadipocytes. Proceedings of the National Academy of Sciences of the United States of America 2006 103 13 5207 5212 2-s2.0-33645521371 10.1073/pnas.0600821103
206. Frey N., Katus H. A., Olson E. N., Hill J. A., Hypertrophy of the heart: a new therapeutic target? Circulation 2004 109 13 1580 1589 2-s2.0-1842579393 10.1161/01.CIR.0000120390.68287.BB (Pubitemid 38451712)
207. De Caterina R., Zampolli A., Del Turco S., Madonna R., Massaro M., Nutritional mechanisms that influence cardiovascular disease. American Journal of Clinical Nutrition 2006 83 2 421S 426S 2-s2.0-33644871978 (Pubitemid 44713212)
208. Wang C., Harris W. S., Chung M., Lichtenstein A. H., Balk E. M., Kupelnick B., Jordan H. S., Lau J., n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: a systematic review. American Journal of Clinical Nutrition 2006 84 1 5 17 2-s2.0-33747120160 (Pubitemid 44699166)